Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of behçet disease: results of an open 4-center trial
Ina Kötter(Asklepios Klinik Altona), Nicole Stübiger(University of Tübingen), Anja Eckstein, Manfred Zierhut, Bodo Grimbacher(University of Freiburg), İlhan Günaydın, Thomas Neß, Sabine Blaschke, Hans Peter(Innsbruck Medical University), Reinhard Vonthein
Cited by 106
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency
|Nature Immunology|2003|730
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721